Backenroth Samuel
Related Filers (2)
Ownership (14)
4
Tuesday, 4/18/2023
Vascular Biogenics Ltd.: Statement of changes in beneficial ownership of securities
3
Tuesday, 1/3/2023
Vascular Biogenics Ltd.: Initial statement of beneficial ownership of securities
4
Wednesday, 12/30/2020
NeuBase Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 5/4/2020
NeuBase Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/16/2019
NeuBase Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/18/2017
Ohr Pharmaceutical Inc: Statement of changes in beneficial ownership of securities
4
Thursday, 4/13/2017
Ohr Pharmaceutical Inc: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/21/2016
Ohr Pharmaceutical Inc: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/24/2016
Ohr Pharmaceutical Inc: Statement of changes in beneficial ownership of securities
4
Monday, 1/11/2016
Ohr Pharmaceutical Inc: Statement of changes in beneficial ownership of securities
4
Thursday, 3/12/2015
Ohr Pharmaceutical Inc: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/10/2015
Ohr Pharmaceutical Inc: Statement of changes in beneficial ownership of securities
4
Monday, 12/8/2014
Ohr Pharmaceutical Inc: Statement of changes in beneficial ownership of securities
3
Monday, 6/24/2013
Ohr Pharmaceutical Inc: Initial statement of beneficial ownership of securities